Prophylaxis Regimen for Hemophilia A Patients

Clinical trial NCT05036278 · COMPLETED

Trial details

NCT number: NCT05036278
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hemophilia A Prophylaxis of Bleeding

Start date: 2022-07-28
Primary completion: 2024-09-12
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.